Takashi Ohashi Selected Research

Takashi Ohashi Research Topics

Disease

7	Infections 01/2012 - 01/2004
5	Multiple Sclerosis 04/2019 - 01/2011
3	Neuromyelitis Optica (Devic's Disease) 01/2016 - 01/2011
3	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 11/2015 - 01/2004
3	Vaccinia 02/2014 - 02/2009
2	Neoplasms (Cancer) 11/2015 - 07/2004
2	T-Cell Leukemia (Leukemia, T Cell) 03/2005 - 01/2004
1	Chronic Progressive Multiple Sclerosis 05/2022
1	Pneumonia (Pneumonitis) 03/2022
1	Hematologic Neoplasms (Hematological Malignancy) 03/2022
1	Acute Kidney Injury (Acute Renal Failure) 03/2022
1	Febrile Neutropenia 03/2022
1	Optic Neuritis (Retrobulbar Neuritis) 12/2021
1	Relapsing-Remitting Multiple Sclerosis 04/2019
1	Encephalitis (Encephalitis, Rasmussen) 11/2017
1	Seizures (Absence Seizure) 11/2017
1	Tuberculoma 01/2017
1	Neurocysticercosis 01/2017
1	Leukoencephalopathies 01/2016
1	Neoplasm Metastasis (Metastasis) 11/2015
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 06/2015
1	Parkinson Disease (Parkinson's Disease) 06/2015
1	Inflammation (Inflammations) 11/2014
1	Human Influenza (Influenza) 01/2012
1	Myxoma (Myxomas) 01/2011
1	Cerebral Infarction 01/2011
1	HTLV-I Infections (HTLV-I Infection) 10/2008
1	Colonic Neoplasms (Colon Cancer) 05/2007
1	Adenoma (Adenomas) 05/2007
1	Polycythemia (Erythrocytosis) 06/2006
1	Acute Erythroblastic Leukemia (Erythroleukemia) 06/2006
1	Hyperplasia 06/2006
1	Lymphoma (Lymphomas) 03/2005
1	Vesicular Stomatitis 09/2004
1	Thrombocytopenia (Thrombopenia) 02/2002
1	Myelitis 02/2002

Drug/Important Bio-Agent (IBA)

3	VaccinesIBA 02/2014 - 03/2005
2	Methylprednisolone FDA LinkGeneric 01/2016 - 11/2014
2	SteroidsIBA 11/2014 - 02/2002
2	AntibodiesIBA 01/2012 - 01/2012
2	Complementary DNA (cDNA)IBA 11/2004 - 01/2004
1	siponimodIBA 05/2022
1	Transaminases (Aminotransferases)IBA 03/2022
1	arbekacinIBA 03/2022
1	HLA-DRB1*04 antigenIBA 12/2021
1	HLA-DRB1 Chains (HLA DRB1)IBA 12/2021
1	Dimethyl FumarateIBA 04/2019
1	dimemorfan (AT 17)IBA 11/2017
1	Adenosine DeaminaseIBA 01/2017
1	Interferon-gamma (Interferon, gamma)IBA 01/2017
1	Praziquantel (Biltricide)FDA Link 01/2017
1	GadoliniumIBA 01/2017
1	Angiotensin Receptor AntagonistsIBA 01/2016
1	OsteopontinIBA 11/2015
1	IntegrinsIBA 11/2015
1	SVVYGLR peptideIBA 11/2015
1	DNA-Binding Proteins (DNA Binding Protein)IBA 06/2015
1	SynucleinsIBA 06/2015
1	CytokinesIBA 11/2014
1	AIDS VaccinesIBA 02/2014
1	GangliosidesIBA 01/2012
1	Neutralizing AntibodiesIBA 01/2012
1	Chemokine ReceptorsIBA 01/2011
1	InterferonsIBA 01/2011
1	Protein Isoforms (Isoforms)IBA 09/2010
1	Antiviral Agents (Antivirals)IBA 05/2009
1	DNA (Deoxyribonucleic Acid)IBA 02/2009
1	gag Gene Products (gag Protein)IBA 02/2009
1	EpitopesIBA 10/2008
1	Peptides (Polypeptides)IBA 10/2008
1	Viral RNAIBA 06/2007
1	tannaseIBA 05/2007
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2006
1	Erythropoietin FDA Link 06/2006
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 06/2006
1	Glycoproteins (Glycoprotein)IBA 06/2006
1	proto-oncogene protein Spi-1IBA 06/2006
1	IntegrasesIBA 11/2004
1	specific substance maruyama (Z-100)IBA 09/2004
1	Immunologic Factors (Immunomodulators)IBA 09/2004
1	Small Interfering RNA (siRNA)IBA 01/2004
1	Cardiolipins (Cardiolipin)IBA 02/2002

Therapy/Procedure

4	Therapeutics 01/2016 - 07/2004
2	Immunotherapy 11/2015 - 03/2005
2	Hematopoietic Stem Cell Transplantation 07/2004 - 01/2004
1	Plasmapheresis 11/2014
1	Contraindications 01/2011
1	Thrombolytic Therapy 01/2011
1	Drug Therapy (Chemotherapy) 01/2004